Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Alibaba
BABA
|
+$138M |
| 2 |
AbbVie
ABBV
|
+$122M |
| 3 |
Zoom
ZM
|
+$109M |
| 4 |
Amazon
AMZN
|
+$105M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$103M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$226M |
| 2 |
RTN
Raytheon Company
RTN
|
+$145M |
| 3 |
Newmont
NEM
|
+$52.9M |
| 4 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$51.2M |
| 5 |
Yum! Brands
YUM
|
+$34.4M |
Sector Composition
| 1 | Technology | 25.6% |
| 2 | Healthcare | 15.16% |
| 3 | Consumer Discretionary | 12.49% |
| 4 | Communication Services | 10.4% |
| 5 | Industrials | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Emergent Biosolutions
EBS
$425M
| $7.81M | 0.01% |
98,700
+13,600
| +16% | +$1.08M |
|
902
Power Integrations
POWI
$2.5B
| $7.79M | 0.01% |
131,800
+17,600
| +15% | +$1.04M |
|
|
SGI
903
Somnigroup International Inc.
SGI
$17.9B
| $7.79M | 0.01% |
432,800
+76,400
| +21% | +$1.37M |
|
|
NEWR
904
DELISTED
New Relic, Inc.
NEWR
| $7.75M | 0.01% |
112,497
+15,600
| +16% | +$1.07M |
|
905
Texas Roadhouse
TXRH
$11B
| $7.74M | 0.01% |
147,200
+19,300
| +15% | +$1.01M |
|
906
Semtech
SMTC
$5.29B
| $7.72M | 0.01% |
147,900
+18,900
| +15% | +$987K |
|
907
Qualys
QLYS
$4.75B
| $7.72M | 0.01% |
74,200
+10,400
| +16% | +$1.08M |
|
|
GBT
908
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $7.71M | 0.01% |
122,200
+5,400
| +5% | +$341K |
|
909
Caesars Entertainment
CZR
$5.33B
| $7.71M | 0.01% |
192,544
+64,300
| +50% | +$2.58M |
|
|
DOC
910
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $7.71M | 0.01% |
439,806
+74,500
| +20% | +$1.31M |
|
911
PVH
PVH
$3.93B
| $7.68M | 0.01% |
159,740
-128,100
| -45% | -$6.16M |
|
912
Lithia Motors
LAD
$8.64B
| $7.67M | 0.01% |
50,700
+6,800
| +15% | +$1.03M |
|
913
Stantec
STN
$12.4B
| $7.66M | 0.01% |
249,670
+32,200
| +15% | +$987K |
|
914
AXIS Capital
AXS
$7.59B
| $7.6M | 0.01% |
187,400
+24,600
| +15% | +$998K |
|
915
Unum
UNM
$12.6B
| $7.6M | 0.01% |
458,108
-342,400
| -43% | -$5.68M |
|
|
ETRN
916
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $7.59M | 0.01% |
913,387
+493,400
| +117% | +$4.1M |
|
917
SouthState Bank Corporation
SSB
$10.3B
| $7.58M | 0.01% |
158,937
+93,535
| +143% | +$4.46M |
|
|
PRSP
918
DELISTED
Perspecta Inc. Common Stock
PRSP
| $7.54M | 0.01% |
324,400
+42,000
| +15% | +$976K |
|
919
Strategic Education
STRA
$1.94B
| $7.54M | 0.01% |
49,038
+6,400
| +15% | +$983K |
|
920
Marriott Vacations Worldwide
VAC
$2.64B
| $7.53M | 0.01% |
91,636
+22,300
| +32% | +$1.83M |
|
921
Integra LifeSciences
IART
$1.21B
| $7.53M | 0.01% |
160,194
+18,600
| +13% | +$874K |
|
922
Simpson Manufacturing
SSD
$7.97B
| $7.52M | 0.01% |
89,100
+11,700
| +15% | +$987K |
|
923
Janus Henderson
JHG
$6.96B
| $7.51M | 0.01% |
354,705
+45,600
| +15% | +$965K |
|
924
Spire
SR
$4.5B
| $7.49M | 0.01% |
114,050
+15,200
| +15% | +$999K |
|
925
Envista
NVST
$3.45B
| $7.49M | 0.01% |
355,300
+63,000
| +22% | +$1.33M |
|